Avinger releases updated data from IMAGE-BTK study in webinar
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 24 2024
0mins
Should l Buy ?
Webinar Overview: Avinger hosted a webinar discussing new approaches to treating Peripheral Artery Disease (PAD) below-the-knee, featuring expert presentations from Dr. Michael Lichtenberg on treatment challenges and future perspectives, and Dr. Thomas Davis on the Pantheris SV device and interim data from the IMAGE-BTK study.
Study Findings: The IMAGE-BTK study demonstrated promising safety and efficacy results for the Pantheris SV device, with 100% freedom from major adverse events at 30 days and high rates of primary patency and freedom from target lesion revascularization at 12 months.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
